Zhen Chang

Beijing, 100069, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A rationally designed cocktail of nanobodies elicited by heterologous vaccination confers protection against SFTSV in preclinical models.

A rationally designed cocktail of nanobodies elicited by heterologous vaccination confers protection against SFTSV in preclinical models.

Journal: Science translational medicine

Published: November 19, 2025

Bispecific antibodies targeting two glycoproteins on SFTSV exhibit synergistic neutralization and protection in a mouse model.

Bispecific antibodies targeting two glycoproteins on SFTSV exhibit synergistic neutralization and protection in a mouse model.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 03, 2024

Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins.

Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins.

Journal: The EMBO journal

Published: October 21, 2023

Correction: Yu et al. Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments. Viruses 2022, 14, 1938.

Correction: Yu et al. Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments. Viruses 2022, 14, 1938.

Journal: Viruses

Published: April 11, 2023

Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments.

Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments.

Journal: Viruses

Published: August 13, 2022

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants.

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants.

Journal: Vaccines

Published: June 15, 2022

Alum/CpG Adjuvanted Inactivated COVID-19 Vaccine with Protective Efficacy against SARS-CoV-2 and Variants.

Alum/CpG Adjuvanted Inactivated COVID-19 Vaccine with Protective Efficacy against SARS-CoV-2 and Variants.

Journal: Vaccines

Published: June 08, 2022

Immunogenicity Evaluating of the Multivalent COVID-19 Inactivated Vaccine against the SARS-CoV-2 Variants.

Immunogenicity Evaluating of the Multivalent COVID-19 Inactivated Vaccine against the SARS-CoV-2 Variants.

Journal: Vaccines

Published: May 23, 2022

An engineered bispecific human monoclonal antibody against SARS-CoV-2.

An engineered bispecific human monoclonal antibody against SARS-CoV-2.

Journal: Nature immunology

Published: September 05, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026